Ferring Pharmaceuticals announced that the FDA has approved a new labeling for Menopur (menotropins for injection) and Bravelle (urofollitropin for injection) stating that both products can be safely mixed and administered in a single injection.
FDA Approves Combo IVF Drugs for Infertility
